arginine has been researched along with merbarone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 6 (85.71) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, TD; Drake, FH; Hofmann, GA; Johnson, RK; Mattern, MR; Mirabelli, CK; Woessner, RD | 1 |
Bartus, JO; Drake, FH; Hertzberg, RP; Hofmann, GA; Johnson, RK; Mattern, MR; Mirabelli, CK; Mong, SM | 1 |
Beck, WT; Chen, M | 2 |
Levac, P; Moss, T | 1 |
Beck, WT; Khélifa, T; Kusumoto, H; Mo, YY; Rodgers, Q; Wang, Q; Wolverton, JS | 1 |
Beck, WT; Mo, YY | 1 |
7 other study(ies) available for arginine and merbarone
Article | Year |
---|---|
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; Cell Nucleus; Cell Transformation, Neoplastic; DNA Damage; DNA Topoisomerases, Type II; Genes, ras; Mice; Molecular Weight; Novobiocin; RNA, Messenger; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors | 1990 |
In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
Topics: Amsacrine; Animals; Antineoplastic Agents; Camptothecin; DNA; DNA Damage; Leukemia, Experimental; Mice; Teniposide; Thiobarbiturates; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1989 |
Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26.
Topics: Cell Division; DNA; DNA Damage; Dose-Response Relationship, Drug; G2 Phase; HeLa Cells; Histones; Humans; Mitosis; S Phase; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors | 1995 |
Teniposide-resistant CEM cells, which express mutant DNA topoisomerase II alpha, when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme.
Topics: Cell Cycle; Chromosomes; DNA; DNA Topoisomerases, Type II; Drug Resistance; Humans; Leukemia; Mutation; Proteins; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
Topics: Camptothecin; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Circular; DNA, Fungal; DNA, Viral; Electrophoresis, Gel, Two-Dimensional; Enzyme Activation; Enzyme Inhibitors; Etoposide; Hypertonic Solutions; Mutation; Plasmids; Recombination, Genetic; Simian virus 40; Teniposide; Thiobarbiturates; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Yeasts | 1996 |
Novel mechanisms of resistance to inhibitors of DNA topoisomerases.
Topics: Antineoplastic Agents; Apoptosis; Cell Nucleus; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Enzyme Inhibitors; G2 Phase; Genes, jun; Humans; Leukemia; RNA, Messenger; Signal Transduction; Teniposide; Thiobarbiturates; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1997 |
DNA damage signals induction of fas ligand in tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; CHO Cells; Cricetinae; DNA; DNA Damage; Doxorubicin; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Jurkat Cells; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Razoxane; Recombinant Fusion Proteins; Signal Transduction; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Up-Regulation | 1999 |